Irinotecan-cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line.
Cancer Chemother Pharmacol. 2007 Jun;60(1):91-102. doi: 10.1007/s00280-006-0353-z. Epub 2006 Sep 29.
Cancer Chemother Pharmacol. 2007.
PMID: 17009029